Document Detail


Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study.
MedLine Citation:
PMID:  19833894     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Because vitamin D deficiency is associated with a variety of chronic diseases, understanding the characteristics that promote vitamin D deficiency in otherwise healthy adults could have important clinical implications. Few studies relating vitamin D deficiency to obesity have included direct measures of adiposity. Furthermore, the degree to which vitamin D is associated with metabolic traits after adjusting for adiposity measures is unclear.
RESEARCH DESIGN AND METHODS: We investigated the relations of serum 25-hydroxyvitamin D (25[OH]D) concentrations with indexes of cardiometabolic risk in 3,890 nondiabetic individuals; 1,882 had subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) volumes measured by multidetector computed tomography (CT).
RESULTS: In multivariable-adjusted regression models, 25(OH)D was inversely associated with winter season, waist circumference, and serum insulin (P < 0.005 for all). In models further adjusted for CT measures, 25(OH)D was inversely related to SAT (-1.1 ng/ml per SD increment in SAT, P = 0.016) and VAT (-2.3 ng/ml per SD, P < 0.0001). The association of 25(OH)D with insulin resistance measures became nonsignificant after adjustment for VAT. Higher adiposity volumes were correlated with lower 25(OH)D across different categories of BMI, including in lean individuals (BMI <25 kg/m(2)). The prevalence of vitamin D deficiency (25[OH]D <20 ng/ml) was threefold higher in those with high SAT and high VAT than in those with low SAT and low VAT (P < 0.0001).
CONCLUSIONS: Vitamin D status is strongly associated with variation in subcutaneous and especially visceral adiposity. The mechanisms by which adiposity promotes vitamin D deficiency warrant further study.
Authors:
Susan Cheng; Joseph M Massaro; Caroline S Fox; Martin G Larson; Michelle J Keyes; Elizabeth L McCabe; Sander J Robins; Christopher J O'Donnell; Udo Hoffmann; Paul F Jacques; Sarah L Booth; Ramachandran S Vasan; Myles Wolf; Thomas J Wang
Related Documents :
17154744 - Does reducing withdrawal severity mediate nicotine patch efficacy? a randomized clinica...
19074094 - Management of excessive anticoagulant effect due to vitamin k antagonists.
19206554 - Nanostructured polyaniline/titanium dioxide composite anode for microbial fuel cells.
16120264 - Paradigm change in evolutionary microbiology.
10576774 - Distinct glucose lowering and beta cell protective effects of vanadium and food restric...
14562524 - Asymptomatic bacteriuria among outpatients with diabetes mellitus in an urban black pop...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2009-10-15
Journal Detail:
Title:  Diabetes     Volume:  59     ISSN:  1939-327X     ISO Abbreviation:  Diabetes     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-12-30     Completed Date:  2010-02-25     Revised Date:  2011-07-19    
Medline Journal Info:
Nlm Unique ID:  0372763     Medline TA:  Diabetes     Country:  United States    
Other Details:
Languages:  eng     Pagination:  242-8     Citation Subset:  AIM; IM    
Affiliation:
Framingham Heart Study, Framingham, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abdominal Fat / anatomy & histology*
Adipose Tissue / anatomy & histology*
Adult
Blood Pressure
Cardiovascular Diseases / epidemiology*
Cholesterol, HDL / blood
Cohort Studies
European Continental Ancestry Group
Female
Glucose Intolerance / epidemiology
Humans
Hypertension / epidemiology
Longitudinal Studies
Male
Middle Aged
Obesity / epidemiology*
Tomography, X-Ray Computed
Triglycerides / blood
Vitamin D / analogs & derivatives*,  blood,  metabolism*
Vitamin D Deficiency / complications*
Grant Support
ID/Acronym/Agency:
N01-HC-25195/HC/NHLBI NIH HHS; R01-DK-80739/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Cholesterol, HDL; 0/Triglycerides; 1406-16-2/Vitamin D; 64719-49-9/25-hydroxyvitamin D
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabol...
Next Document:  Hippocampal volumes in youth with type 1 diabetes.